1.
Bioorg Med Chem Lett
; 20(5): 1543-7, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20137931
RESUMO
The work described herein demonstrates the utility of structure-based drug design (SBDD) in shifting the binding mode of an HTS hit from a DFG-in to a DFG-out binding mode resulting in a class of novel potent CSF-1R kinase inhibitors suitable for lead development.